The use of imagent BP as a blood pool contrast agent to visualize and quantitate liver tumor burden

G. C. Steinbach, K. G. Baker, G. L. Lim, R. F. Mattrey, R. S. Arellano

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


The accurate quantitation of liver tumor burden and visualization of lesions in three dimensions (3D) can assist in treatment planning and can allow monitoring of therapy. Previous attempts have used CT and standard contrast media. Because the iodinated agents rapidly diffuse into tumors, usually effacing, and at time enhancing tumor edges, they decrease accuracy and make image segmentation difficult. CT portography suffers from flow related artifacts and does not allow the distinction of tumors from hemangiomas. Blood pool contrast is ideal in this setting since it enhances liver, liver vessels and hemangiomas, but not tumors, ‘physiologically’ splitting the image into normal and abnormal tissues. This ongoing study assesses the feasibility of this technique to visualize tumor and presents a scheme to automatically quantitate tumor volume. It utilized a rabbit VX2 liver tumor model and CT scanning shortly after the infusion of 3 ml/kg perflubron emulsion Cut sections of the frozen carcass served as gross pathologic correlation. Images were imported onto a Sparc workstation, 3D reformatted and tumor and liver volume calculated. Histograms of pixel intensity clearly separated tumors from liver and liver from surrounding structures allowing the easy demarcation of tumor and liver margins.

Original languageEnglish (US)
Pages (from-to)1501-1509
Number of pages9
JournalArtificial Cells, Blood Substitutes, and Biotechnology
Issue number4
StatePublished - Jan 1994

ASJC Scopus subject areas

  • Biotechnology
  • Biomedical Engineering


Dive into the research topics of 'The use of imagent BP as a blood pool contrast agent to visualize and quantitate liver tumor burden'. Together they form a unique fingerprint.

Cite this